Welcome to LookChem.com Sign In|Join Free

CAS

  • or

173656-97-8

Post Buying Request

173656-97-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

173656-97-8 Usage

Explanation

Different sources of media describe the Explanation of 173656-97-8 differently. You can refer to the following data:
1. The compound is composed of 18 carbon atoms, 20 hydrogen atoms, 2 nitrogen atoms, and 4 oxygen atoms.
2. The compound is derived from pyridazine dicarboxylic acid by adding four hydrogen atoms to the molecule, resulting in a saturated structure.
3. The compound contains a methyl group (CH3) attached to the tetrahydro pyridazine dicarboxylic acid structure.
4. The compound has a phenylmethyl ester group, which is a phenyl group (C6H5) attached to a methyl group (CH2), connected to the molecule.
5. (S)-enantiomer
5. The compound exists in two enantiomeric forms, and the (S)-enantiomer is the one specified in the name. Enantiomers are non-superimposable mirror images of each other, and they have different spatial arrangements of atoms.
6. The (S)-enantiomer designation indicates that the compound has a chiral center, which is an atom with four different groups attached to it, leading to the formation of enantiomers.
7. The specific uses and potential applications of this compound are not mentioned in its name, so further information would be needed to understand its properties and potential uses.
8. The specific chemical properties of this compound, such as reactivity, solubility, and stability, cannot be determined without additional information.
9. The specific physical properties of this compound, such as melting point, boiling point, and density, cannot be determined without additional information.

Structure

Tetrahydro derivative of pyridazine dicarboxylic acid

Methyl group

CH3

Phenylmethyl ester

C6H5CH2

Chirality

Presence of a chiral center

Uses and potential applications

Not specified in the name

Chemical properties

Unknown without further information

Physical properties

Unknown without further information

Check Digit Verification of cas no

The CAS Registry Mumber 173656-97-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,3,6,5 and 6 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 173656-97:
(8*1)+(7*7)+(6*3)+(5*6)+(4*5)+(3*6)+(2*9)+(1*7)=168
168 % 10 = 8
So 173656-97-8 is a valid CAS Registry Number.

173656-97-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl (S)-1-benzyloxycarbonylhexahydropyridazine-3-carboxylate

1.2 Other means of identification

Product number -
Other names (3S)-N1-Cbz-piperazic acid methyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:173656-97-8 SDS

173656-97-8Relevant articles and documents

Total synthesis of padanamides A and B

Long, Bohua,Tang, Shoubin,Chen, Ligong,Qu, Shiwei,Chen, Bo,Liu, Junyang,Maguire, Anita R.,Wang, Zhuo,Liu, Yuqing,Zhang, Hui,Xu, Zhengshuang,Ye, Tao

supporting information, p. 2977 - 2979 (2013/05/22)

The first total syntheses of padanamides A and B have been achieved, unambiguously confirming their structures. The Royal Society of Chemistry.

Hexahydropyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and methods of preparation

-

Page/Page column 9, (2010/02/13)

The present invention discloses and claims compounds of formula (I) as inhibitors of proteases and kinases, method using said compounds of formula (I) for the prevention or treatment of certain cardiovascular, central nervous system, inflammatory, and bon

Enantioselective syntheses of (R)- and (S)-hexahydropyridazine-3-carboxylic acid derivatives

Schmidt, Ulrich,Braun, Christine,Sutoris, Heinz

, p. 223 - 229 (2007/10/03)

Appropriately protected optically active tetrahydropyridazine-3-carboxylic acid and hexahydropyridazine-3-carboxylic acid were prepared via ring closure of α-hydrazino- and δ-hydrazinopentanoates. Either optically active glutamic acid or an enantioselective catalytic hydrogenation was used to generate the chiral center. The numerous optically active intermediates are valuable starting materials for the synthesis of other unusual amino acids.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 173656-97-8